Uncomplicated Plasmodium Falciparum Malaria Clinical Trial
Official title:
A Multi-part, Multi-center PLATform Study to Assess the Efficacy, Safety, Tolerability and Pharmacokinetics of Anti-malarial Agents Administered as Monotherapy and/or Combination Therapy IN Patients With Uncomplicated Plasmodium Falciparum Malaria
Platform study to evaluate the efficacy and safety of anti-malarial agents in patients with uncomplicated Plasmodium falciparum malaria
The purpose of this platform study is to evaluate the parasiticidal effect and potential for cure with different anti-malarial agents administered as monotherapy and/or in combination therapy with other anti-malarial agents in adult and adolescent patients with uncomplicated Plasmodium falciparum malaria. Additionally, the safety, tolerability, and pharmacokinetics of these anti-malarial agents will be evaluated for dose selection for future studies. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06076213 -
Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo
|
Phase 4 | |
| Recruiting |
NCT05842954 -
Efficacy, Safety and Tolerability of KLU156 in Adults and Children ≥ 5 kg Body Weight With Uncomplicated P. Falciparum Malaria
|
Phase 3 | |
| Completed |
NCT00301015 -
Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Health Workers
|
Phase 4 | |
| Completed |
NCT00331136 -
Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria
|
Phase 2 | |
| Completed |
NCT02083380 -
Phase IIb Study to Investigate the Efficacy of OZ439 & Piperaquine Phosphate Co-administered to Adults & Children With Uncomplicated Plasmodium Falciparum.
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT05951595 -
A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines
|
Phase 3 | |
| Completed |
NCT03453840 -
Extended Duration Artemether-lumefantrine Treatment for Malaria in Children
|
Phase 4 | |
| Recruiting |
NCT04546633 -
Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria
|
Phase 2 | |
| Suspended |
NCT01849640 -
Antimalarial Drug Resistance With Assessment of Transmission Blocking Activity
|
N/A | |
| Not yet recruiting |
NCT05764746 -
Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial
|
Phase 2/Phase 3 |